A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 5, Issue 3, Pages 331-338
Publisher
Wiley
Online
2016-01-08
DOI
10.5966/sctm.2015-0168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- Metastatic Colorectal Cancer: Current State and Future Directions
- (2015) Marwan G. Fakih JOURNAL OF CLINICAL ONCOLOGY
- A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
- (2015) J. Rios-Doria et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the root of cancer relapse
- (2015) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells
- (2014) F Fan et al. BRITISH JOURNAL OF CANCER
- Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding
- (2014) Timo Effenberger et al. FASEB JOURNAL
- Targeting the Sheddase Activity of ADAM17 by an Anti-ADAM17 Antibody D1(A12) Inhibits Head and Neck Squamous Cell Carcinoma Cell Proliferation and Motility via Blockage of Bradykinin Induced HERs Transactivation
- (2014) Yanchao Huang et al. International Journal of Biological Sciences
- Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
- (2013) Jia Lu et al. CANCER CELL
- miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer
- (2013) C.-C. Yu et al. CANCER RESEARCH
- Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium
- (2013) R Wang et al. CELL DEATH AND DIFFERENTIATION
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells
- (2013) Xiangrong Chen et al. NEUROSCIENCE LETTERS
- Targeting cancer stem cells to suppress acquired chemotherapy resistance
- (2013) S J Vidal et al. ONCOGENE
- Role of targeted agents in metastatic colorectal cancer
- (2013) Hans Prenen et al. Targeted Oncology
- ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
- (2013) Pachiyappan Kamarajan et al. Cancer Medicine
- ADAM-17: a novel therapeutic target for triple negative breast cancer
- (2012) P. M. McGowan et al. ANNALS OF ONCOLOGY
- Colon cancer stem cells – From basic to clinical application
- (2012) Galina Botchkina CANCER LETTERS
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
- (2012) Jian Yang et al. STEM CELLS
- Treatment of Metastatic Colorectal Cancer
- (2011) Janine M. Davies et al. SEMINARS IN ONCOLOGY
- ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer
- (2010) A. Baumgart et al. CANCER RESEARCH
- Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17
- (2010) S. Van Schaeybroeck et al. CANCER RESEARCH
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Colon Cancer Stem Cells: Promise of Targeted Therapy
- (2010) Matilde Todaro et al. GASTROENTEROLOGY
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- ADAM17 as a Therapeutic Target in Multiple Diseases
- (2009) Joaquin Arribas et al. CURRENT PHARMACEUTICAL DESIGN
- TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer
- (2008) N. B. Merchant et al. CLINICAL CANCER RESEARCH
- The role of Delta-like 1 shedding in muscle cell self-renewal and differentiation
- (2008) D. Sun et al. JOURNAL OF CELL SCIENCE
- Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer
- (2008) Erick Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More